Details

Description

Release form

Vizin.

Eye drops.

Packaging

15 ml - plastic bottles with a dropper (1) - cardboard packs.

pharmachologic effect

Alpha adrenergic agonist.

Tetrizoline stimulates β-adrenergic receptors of the sympathetic nervous system, does not have or has a weak effect on β-adrenergic receptors.

Has a vasoconstrictor effect and reduces tissue edema.

The action of the drug begins 60 seconds after instillation and lasts 4-8 hours.

Pharmacokinetics

Tetrizoline is practically not absorbed when applied topically.

Detailed pharmacokinetic studies with the use of eye drops have not been conducted.

Indications

Edema and hyperemia of the conjunctiva arising from allergies or due to the effects of chemical and physical factors (smoke, dust, chlorinated water, light, cosmetics, contact lenses).

The drug is prescribed for adults and children over 2 years of age.

For children under 6 years of age, the drug is prescribed under medical supervision.

Contraindications

endothelial-epithelial corneal dystrophy

angle-closure glaucoma

children under 2 years old

hypersensitivity to drug components.

The drug should be used with caution in severe cardiovascular diseases (for example, ischemic heart disease, arterial hypertension, arrhythmias, aneurysm), hyperthyroidism, diabetes mellitus, pheochromocytoma and in patients receiving MAO inhibitors or other drugs that can increase blood pressure.

Application during pregnancy and lactation

Taking into account the risk of developing systemic adverse reactions, the use of the drug during pregnancy and lactation (breastfeeding) is possible only in cases where the intended benefit of therapy to the mother outweighs the potential risk to the fetus or infant.

special instructions

Before instilling the drug, it is necessary to remove contact lenses and install them about 15 minutes after instillation.

It is advisable to use the drug only with mild eye irritation.

The patient should be warned that if within 48 hours the condition does not improve or irritation and hyperemia persist or increase, the drug should be discontinued and a doctor should be consulted.

The patient should be informed that in case of intense pain in the eyes, headache, loss of vision, sudden appearance of floating" spots in front of the eyes, with redness of the eyes, pain when exposed to light or if double vision appears in the eyes, immediately consult a doctor.

Do not use the drug if irritation or hyperemia is associated with serious diseases of the organ of vision, such as infection, foreign body or chemical trauma to the cornea.

The patient should be informed that if the medicinal product has become unusable or the expiration date has expired, then it should not be thrown into the wastewater or on the street.

Place the medicine in a bag and put it in the trash can.

These measures will help protect the environment.

Influence on the ability to drive vehicles and use mechanisms

In rare cases, after the use of eye drops, pupil dilation is observed and blurred vision occurs, which can affect the ability to drive a car or machinery.

Structure

1 ml - tetrizoline hydrochloride 500 mcg

Excipients: boric acid, sodium chloride, disodium edetate, benzalkonium chloride solution 17%, sodium borate, purified water.

Method of administration and dosage

Instill 1-2 drops into the affected eye 2-3 times / day.

Continuous use of the drug for more than 4 days is not recommended.

When instilling, it is necessary to remove the cap from the dropper bottle and turn the bottle over.

Avoid touching the dropper tip to any surfaces.

After use, screw the cap of the dropper bottle.

Side effects

From the side of the organ of vision: in rare cases - a burning sensation, redness of the eye, pain and tingling in the eye, blurred vision, ra

Name ENG

VISINE CLASSIC

Clinical and pharmacological group

Alpha-adrenergic agonist for topical use in ophthalmology

ATX code

Tetryzoline

Dosage

0.05% x 15ml

Structure

1 ml - tetrizoline hydrochloride 500 mcg.

Excipients: boric acid, sodium chloride, disodium edetate, benzalkonium chloride solution 17%, sodium borate, purified water.

Indications

Edema and hyperemia of the conjunctiva arising from allergies or due to the effects of chemical and physical factors (smoke, dust, chlorinated water, light, cosmetics, contact lenses).

The drug is prescribed for adults and children over 2 years of age.

For children under 6 years of age, the drug is prescribed under medical supervision.

Contraindications

endothelial-epithelial corneal dystrophy

angle-closure glaucoma

children under 2 years of age

hypersensitivity to drug components.

The drug should be used with caution in severe cardiovascular diseases (for example, ischemic heart disease, arterial hypertension, arrhythmias, aneurysm), hyperthyroidism, diabetes mellitus, pheochromocytoma and in patients receiving MAO inhibitors or other drugs that can increase blood pressure.

INN / Active ingredient

tetrizoline

Storage conditions and periods

At a temperature not higher than 30 degrees.

Expiration date: 3 years

Specifications